Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Long-term safety is uncharacterized
Gastrointestinal adverse events were predominantly limited to initial dosing, while dose escalation resulted in lower discontinuation rates owing to these adverse events than among patients who remained on the starting dose
doi:10.1093/nar/gkt1015 Ugliano, M., Kwiatkowski, M., Vidal, S., Capone, D., Siebert, T., Dieval, J.-B., Aagaard, O., & Waters, E
10.1007/s00125-017-4350-z 80
Despite these defenses, plaintiffs attorneys emphasize the real-life impact of gastroparesis on their clients, which they believe will be more compelling in court
US$ 21.21
US$ 20.65
US$ 21.34
US$ 29.03
